Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Daniel Faulkner

2PUBLICATIONS

17CO-AUTHORS

Innate immunityMedical infection agents (incl. prions)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jul 21, 2025

Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial.

Dean A Fennell, Kayleigh Hill, Min Zhang

|Aug 21, 2024

A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma.

Min Zhang, Aleksandra Bzura, Essa Y Baitei

Pageof 1

Frequent Collaborators

2 joint publications

Zisen Zhou

2 joint publications

Joanna Dzialo

2 joint publications

Edward J Hollox

2 joint publications

Astero Klampatsa

2 joint publications

Dean A Fennell

2 joint publications

Hongji Yang

1 joint publications

Jake B Spicer

1 joint publications

Tamihiro Kamata

1 joint publications

Alastair Greystoke

1 joint publications

Harriet Walter

Frequent Collaborators

2 joint publications

Zisen Zhou

2 joint publications

Joanna Dzialo

2 joint publications

Edward J Hollox

2 joint publications

Astero Klampatsa

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

See more related videos